This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts initiated coverage on several stocks with bullish outlooks. Compass Point's Ed Engel started coverage on Charles Schwab (SCHW) with a Buy rating and $135 price target, noting its Friday close at $105.24. BTIG's Julian Harrison initiated Yarrow Bioscience (YARW) with a Buy rating and $58 target, while Wells Fargo's Derek Archila covered Pyxis Oncology (PYXS) with an Overweight rating and $12 target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Compass Point analyst Ed Engel initiated coverage on Charles Schwab Corporation (NYSE:SCHW) with a Buy rating and announced a price target of $135. Charles Schwab closed at $105.24 on Friday. See how other analysts view this stock.
- BTIG analyst Julian Harrison initiated coverage on Yarrow Bioscience Inc (NASDAQ:YARW) with a Buy rating and announced a price target of $58. Yarrow Bioscience shares closed at $35.02 on Friday. See how other analysts view this stock.
- Wells Fargo analyst Derek Archila initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS) with an Overweight rating and announced a price target of $12. Pyxis Oncology closed at $2.65 on Friday. See how other analysts view this stock.
Considering buying SCHW stock? Here’s what analysts think:
Photo via Shutterstock